Crossover Study to Assess the Bioequivalence of Hydrocodone Bitartrate Extended-Release Tablet
- Study Title
- A Crossover Study to Assess the Bioequivalence of Hydrocodone Bitartrate Extended-Release Tablet
- Teva Identifier
- C33237/1106
- ClinicalTrials.gov Identifier
- NCT01758978
- Study Status
- Completed
- Trial Condition(s)
- Pain
- Interventions
- Drug: a 60 mg dose of the hydrocodone bitartrate extended-release tablet administered as either two 30-mg tablets (Treatment A) or one 60-mg tablet (Treatment B).
- Study Description
- Please refer to ClinicalTrials.gov for a description of the trial
Key Participation Requirements
- Gender
- Female, Male
- Age group
- Adult
- Age Range
- 18 Years to 45 Years
- Trial Duration
- 12/01/2012 - 01/01/2013
- Phase
- Phase 1
